T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KBAL
2126
DELISTED
Kimball International
KBAL
| $474K | ﹤0.01% |
27,179
+100
| +0.4% | +$1.58K |
|
|
UCTT
2127
Ultra Clean Holdings
UCTT
$4.1B
| $472K | ﹤0.01% |
33,923
+4,600
| +16% | +$58.6K |
|
2128
Arbor Realty Trust
ABR
$974M
| $471K | ﹤0.01% |
38,880
-1,193
| -3% | -$15.5K |
|
2129
Global Net Lease
GNL
$1.9B
| $469K | ﹤0.01% |
23,894
+303
| +1% | +$5.77K |
|
2130
Vishay Precision Group
VPG
$934M
| $468K | ﹤0.01% |
11,523
+23
| +0.2% | +$871 |
|
|
ZEUS
2131
DELISTED
Olympic Steel
ZEUS
| $468K | ﹤0.01% |
34,253
+29
| +0.1% | +$431 |
|
2132
Synaptics
SYNA
$4.3B
| $465K | ﹤0.01% |
15,972
-165,685
| -91% | -$5.4M |
|
2133
Ennis
EBF
$556M
| $464K | ﹤0.01% |
22,599
| – | – |
|
2134
New Oriental
EDU
$8.49B
| $464K | ﹤0.01% |
4,800
+300
| +7% | +$26.9K |
|
|
TRST
2135
Trustco Bank Corp NY
TRST
$963M
| $463K | ﹤0.01% |
11,697
+34
| +0.3% | +$1.32K |
|
2136
Primoris Services
PRIM
$4.39B
| $462K | ﹤0.01% |
22,063
+181
| +0.8% | +$3.71K |
|
2137
Axcelis
ACLS
$4.39B
| $459K | ﹤0.01% |
30,512
+100
| +0.3% | +$1.79K |
|
2138
Hanmi Financial
HAFC
$956M
| $457K | ﹤0.01% |
20,500
+139
| +0.7% | +$3.08K |
|
|
NWLI
2139
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $457K | ﹤0.01% |
1,778
+2
| +0.1% | +$532 |
|
2140
LivePerson
LPSN
$34.1M
| $456K | ﹤0.01% |
1,083
+11
| +1% | +$4.69K |
|
2141
Lindsay Corp
LNN
$1.18B
| $453K | ﹤0.01% |
5,505
+30
| +0.5% | +$2.51K |
|
2142
Northern Oil and Gas
NOG
$2.57B
| $453K | ﹤0.01% |
23,461
+208
| +0.9% | +$4.81K |
|
2143
Hawthorn Bancshares
HWBK
$276M
| $451K | ﹤0.01% |
19,671
+125
| +0.6% | +$2.63K |
|
|
TBI
2144
Trueblue
TBI
$302M
| $450K | ﹤0.01% |
20,394
| – | – |
|
|
LION
2145
DELISTED
Fidelity Southern Corporation
LION
| $449K | ﹤0.01% |
14,495
| – | – |
|
|
SPPI
2146
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $446K | ﹤0.01% |
51,791
+486
| +0.9% | +$4.35K |
|
|
GNC
2147
DELISTED
GNC Holdings, Inc.
GNC
| $446K | ﹤0.01% |
297,053
+200
| +0.1% | +$379 |
|
|
KNL
2148
DELISTED
Knoll, Inc.
KNL
| $446K | ﹤0.01% |
19,428
+174
| +0.9% | +$3.61K |
|
2149
Cato Corp
CATO
$65.7M
| $445K | ﹤0.01% |
36,109
| – | – |
|
2150
Universal Electronics
UEIC
$75.8M
| $445K | ﹤0.01% |
10,845
+28
| +0.3% | +$1.12K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.